Header cover image

Project AP-G 2025 And Performance Chemicals Poised To Boost Profit Margins And Revenue Growth

WA
Consensus Narrative from 11 Analysts

Published

January 05 2025

Updated

January 05 2025

Narratives are currently in beta

Key Takeaways

  • Strategic reforms and pricing initiatives aimed at high-growth segments are set to enhance profit margins and streamline operations.
  • Accelerated capital efficiency efforts and demand recovery in key segments position the company for sustained revenue growth and improved earnings.
  • Foreign exchange fluctuations and macroeconomic risks, including market-specific challenges and high-cost business ventures, threaten Toray's revenue, profitability, and net margins.

Catalysts

About Toray Industries
    Manufactures, processes, and sells fibers and textiles, performance chemicals, carbon fiber composite materials, environment and engineering products, and life science products in Japan, China, North America, Europe, and internationally.
What are the underlying business or industry changes driving this perspective?
  • The company's policy to accelerate capital efficiency by reducing cross-shareholdings, with proceeds directed towards share buybacks, is expected to enhance earnings per share by reducing the outstanding share count.
  • The demand recovery and improved utilization rates in high-margin segments like Performance Chemicals and Carbon Fiber Composite Materials are likely to positively impact revenue and net margins in the future.
  • Strategic pricing initiatives are projected to improve core operating income by more than ¥10 billion, contributing to enhanced profit margins.
  • The implementation of business structure reforms, including Project AP-G 2025 and the D Pro profitability improvement projects, is anticipated to streamline operations and boost net margins by focusing on high-growth and high-profitability segments.
  • The global and Japanese economic recovery, along with strategic investments in R&D and capital expenditure, position the company for sustained revenue growth and improved operating income.

Toray Industries Earnings and Revenue Growth

Toray Industries Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming Toray Industries's revenue will grow by 4.6% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 1.9% today to 4.2% in 3 years time.
  • Analysts expect earnings to reach ¥121.7 billion (and earnings per share of ¥81.26) by about January 2028, up from ¥48.6 billion today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting ¥141.1 billion in earnings, and the most bearish expecting ¥100.4 billion.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 15.7x on those 2028 earnings, down from 32.9x today. This future PE is lower than the current PE for the JP Chemicals industry at 19.9x.
  • Analysts expect the number of shares outstanding to decline by 2.04% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 6.11%, as per the Simply Wall St company report.

Toray Industries Future Earnings Per Share Growth

Toray Industries Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • Foreign exchange fluctuations, particularly the appreciation of the yen, have negatively impacted Toray's total assets and liabilities by decreasing the translated yen from its overseas subsidiaries, which could affect revenue and profitability.
  • The Life Science segment experienced a decline in core operating income due to the penetration of generic drug versions and NHI drug price revisions, which impacts net margins and earnings.
  • The potential for changes in fiscal and trade policies, prolonged real estate recession in China, and monetary policy shifts by the Bank of Japan represent macroeconomic risks that may impact Toray's overall revenue and net earnings.
  • The high-cost nature of large capital investment businesses, especially those that are low growth and low profitability, pose a risk to net margins and overall financial health despite strategic initiatives to address these issues.
  • The slight delay in the development of differentiated products in the PP spunbond business may affect the timeline for profitability gains, which can negatively impact future earnings and net margins.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of ¥1065.45 for Toray Industries based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of ¥1300.0, and the most bearish reporting a price target of just ¥870.0.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be ¥2929.6 billion, earnings will come to ¥121.7 billion, and it would be trading on a PE ratio of 15.7x, assuming you use a discount rate of 6.1%.
  • Given the current share price of ¥1001.5, the analyst's price target of ¥1065.45 is 6.0% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

How well do narratives help inform your perspective?

Disclaimer

Warren A.I. is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by Warren A.I. are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that Warren A.I.'s analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

Fair Value
JP¥1.1k
4.1% undervalued intrinsic discount
WarrenAI's Fair Value
Future estimation in
PastFuture0500b1t2t2t3t3t2014201720202023202520262028Revenue JP¥3.1tEarnings JP¥130.4b
% p.a.
Decrease
Increase
Current revenue growth rate
4.42%
Chemicals revenue growth rate
1.52%